Epidemiology of New Psychoactive Substances in Relation to Traditional Drugs of Abuse in Clinical Oral Fluid Samples
Open Access
- 13 January 2025
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 136 (2) , e14117
Abstract
New psychoactive substances (NPS) are health‐hazardous through unpredictable toxicity and effects and largely unknown epidemiology, motivating studies of the latter.Up to 138 NPS were retrospectively identified using liquid chromatography‐high resolution mass spectrometry data from all 34 183 oral fluid drug samples collected in one Swedish health care region 2019–2020 representing 9468 psychiatric and addiction care patients. In total, 618 findings representing 58 NPS were detected in 481 samples from 201 patients. Male gender and age ≥25 years correlated positively with NPS use. Ketamine correlated positively with all NPS classes except cannabinoids; additionally, fentanyl, methadone, tapentadol and clonazepam correlated with multiple NPS classes. More numerous traditional drugs of abuse (DoA) correlated positively with sedative/hypnotic NPS, indicating that these are used in broader patient groups than other NPS. Mitragynine correlated negatively with other NPS in general and with several traditional DoA, but positively with the potential opioid abstinence remedies buprenorphine, loperamide and tapentadol aside from ketamine. In conclusion, NPS use is infrequent but occur also at higher ages, certain traditional DoA and particularly ketamine could have clinical value as NPS use signals, and mitragynine exhibited an atypical NPS consumption pattern indicating significant use as an opioid abstinence remedy.Keywords
Funding Information
- VINNOVA (2017‐02393)
- Västra Götalandsregionen (HS 2017‐00497, RS 2016‐04238)
This publication has 46 references indexed in Scilit:
- Application of a screening method for fentanyl and its analogues using UHPLC‐QTOF‐MS with data‐independent acquisition (DIA) in MSE mode and retrospective analysis of authentic forensic blood samplesDrug Testing and Analysis, 2017
- Acrylfentanyl: Another new psychoactive drug with fatal consequencesForensic Science International, 2017
- Prevalence of new psychoactive substances and prescription drugs in the Belgian driving under the influence of drugs populationDrug Testing and Analysis, 2017
- Postmortem and Toxicological Findings in a Series of Furanylfentanyl-Related DeathsJournal of Analytical Toxicology, 2016
- Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United StatesThe American Journal on Addictions, 2016
- New psychoactive substance use among regular psychostimulant users in Australia, 2010–2015Drug and Alcohol Dependence, 2016
- New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screeningHuman Psychopharmacology: Clinical and Experimental, 2016
- Impairment due to amphetamines and benzodiazepines, alone and in combinationDrug and Alcohol Dependence, 2014
- New psychoactive substances as adulterants of controlled drugs. A worrying phenomenon?Drug Testing and Analysis, 2014
- Treatment or “high”: Benzodiazepine use in patients on injectable heroin or oral opioidsAddictive Behaviors, 2013